News-Medical.Net on MSN
Targeted PET/CT tracer improves early prediction of treatment response in rheumatoid arthritis patients
A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and ...
A new study suggests that following the Mediterranean diet may reduce the risk of rheumatoid arthritis. Rheumatoid arthritis (RA) is an autoimmune disease with several potential causes. Researchers ...
Rheumatoid arthritis (RA) is a chronic inflammatory condition that causes joint and muscle pain. There’s no cure for RA, but early treatment can help manage the condition, keep you active, and improve ...
A new study has found that treating people at high risk of developing rheumatoid arthritis with a rheumatoid arthritis medication may help delay disease onset for several years. As of 2021, about 17.9 ...
MedPage Today on MSN
Rheumatoid Arthritis: How Best to Gauge ILD Risk in Light of Comorbidities?
Standard tools don't help, study finds, but a specialized assessment does ...
Matthew Farrow does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Everyday Health on MSN
How I manage my lupus while also coping with rheumatoid arthritis
Shontia Matlock shares her experience managing lupus and rheumatoid arthritis. Discover how she navigates treatment, faces emotional challenges, and advocates for herself.
Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...
Rheumatoid arthritis (RA) often impacts your ankles, with many individuals experiencing foot and ankle issues early in the disease. Prompt medical care is key to slowing progression with appropriate ...
A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated ...
On February 2, 2024, the voices of many people who have rheumatoid disease will be heard. Rheumatoid disease, also known as rheumatoid arthritis (RA), is an autoimmune condition in which the body ...
Rheumatoid arthritis is one of the most common immune-mediated diseases. Its primary manifestation is inflammatory arthritis characterized by symmetric, polyarticular pain and swelling, typically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results